For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $21.20 in the prior trading day, Adma Biologics Inc (NASDAQ: ADMA) closed at $19.98, down -5.75%. In other words, the price has decreased by -$5.75 from its previous closing price. On the day, 4.13 million shares were traded.
Ratios:
Our goal is to gain a better understanding of ADMA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 66.60 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 52.62. For the most recent quarter (mrq), Quick Ratio is recorded 3.36 and its Current Ratio is at 6.58. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 15 ’25 when Grossman Adam S sold 21,000 shares for $21.46 per share. The transaction valued at 450,660 led to the insider holds 2,055,850 shares of the business.
Grossman Adam S sold 21,000 shares of ADMA for $397,320 on Mar 19 ’25. The President and CEO now owns 2,061,850 shares after completing the transaction at $18.92 per share. On Mar 19 ’25, another insider, Grossman Adam S, who serves as the Director and Officer of the company, bought 84,000 shares for $18.71 each.
Valuation Measures:
As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.67, and their Forward P/E ratio for the next fiscal year is 20.46. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.38 while its Price-to-Book (P/B) ratio in mrq is 12.76.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $25.67, while it has fallen to a 52-week low of $6.84. The 50-Day Moving Average of the stock is -0.29%, while the 200-Day Moving Average is calculated to be 10.07%.
Shares Statistics:
A total of 238.53M shares are outstanding, with a floating share count of 230.39M. Insiders hold about 3.49% of the company’s shares, while institutions hold 84.15% stake in the company.
